A randomized, double blind, vehicle-controlled multicenter phase III study to evaluate the safety and efficacy of BF-200 ALA and narrowband red light in the treatment of superficial basal cell carcinoma (sBCC) with photodynamic therapy (PDT). J of Skin [Internet]. 2019 Nov. 9 [cited 2026 May 2];3:S48. Available from: https://skin.dermsquared.com/skin/article/view/776